ITA0151
ITA0151
ITA0151
from
$526.00
Price in reward points: 526
- Catalog: ITA0151
- Gene/Protein: MMP16
- Product Description: Immunotag™ MMP16 Antibody
Available Options
-
Description
Immunotag™ MMP16 Antibody
-
Specifications
Antibody Specification Datasheet 
IMPORTANT NOTE This product is custom manufactured with a lead time of 3-4 weeks. Once in production, this item cannot be cancelled from an order and is not eligible for return. Target Protein MMP16 Clonality Polyclonal Storage/Stability -20°C/1 year Application WB,IHC,IF/ICC,ELISA Recommended Dilution WB: 1:500~1:3000 IHC: 1:50~1:200, IF/ICC 1:100-1:500 Concentration 1 mg/ml Reactive Species Human,Mouse,Rat Host Species Rabbit Immunogen A synthesized peptide derived from human MMP16 Specificity MMP16 antibody detects endogenous levels of total MMP16 Purification The antiserum was purified by peptide affinity chromatography. Form Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt Gene Name MMP16 Accession No. P51512 Alternate Names C8orf57; DKFZp761D112; Matrix metalloproteinase 16; Matrix metalloproteinase-16; Membrane type 3 matrix metalloproteinase; Membrane type matrix metalloproteinase 3; Membrane-type matrix metalloproteinase 3; Membrane-type-3 matrix metalloproteinase; MMP 16; MMP-16; MMP-X2; MMP16; MMP16_HUMAN; MT-MMP 3; MT-MMP2; MT-MMP3; MT3-MMP; MT3MMP; MTMMP2; MTMMP3; Putative transmembrane protein C8orf57; Description Endopeptidase that degrades various components of the extracellular matrix, such as collagen type III and fibronectin. Activates progelatinase A. Involved in the matrix remodeling of blood vessels. Isoform short cleaves fibronectin and also collagen type III, but at lower rate. It has no effect on type I, II, IV and V collagen. However, upon interaction with CSPG4, it may be involved in degradation and invasion of type I collagen by melanoma cells. Cell Pathway/ Category Primary Polyclonal Antibody Protein MW 69kDa Usage For Research Use Only! Not for diagnostic or therapeutic procedures. - Reviews
| Antibody Specification | |
| Datasheet |
|
| IMPORTANT NOTE | This product is custom manufactured with a lead time of 3-4 weeks. Once in production, this item cannot be cancelled from an order and is not eligible for return. |
| Target Protein | MMP16 |
| Clonality | Polyclonal |
| Storage/Stability | -20°C/1 year |
| Application | WB,IHC,IF/ICC,ELISA |
| Recommended Dilution | WB: 1:500~1:3000 IHC: 1:50~1:200, IF/ICC 1:100-1:500 |
| Concentration | 1 mg/ml |
| Reactive Species | Human,Mouse,Rat |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human MMP16 |
| Specificity | MMP16 antibody detects endogenous levels of total MMP16 |
| Purification | The antiserum was purified by peptide affinity chromatography. |
| Form | Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt |
| Gene Name | MMP16 |
| Accession No. | P51512 |
| Alternate Names | C8orf57; DKFZp761D112; Matrix metalloproteinase 16; Matrix metalloproteinase-16; Membrane type 3 matrix metalloproteinase; Membrane type matrix metalloproteinase 3; Membrane-type matrix metalloproteinase 3; Membrane-type-3 matrix metalloproteinase; MMP 16; MMP-16; MMP-X2; MMP16; MMP16_HUMAN; MT-MMP 3; MT-MMP2; MT-MMP3; MT3-MMP; MT3MMP; MTMMP2; MTMMP3; Putative transmembrane protein C8orf57; |
| Description | Endopeptidase that degrades various components of the extracellular matrix, such as collagen type III and fibronectin. Activates progelatinase A. Involved in the matrix remodeling of blood vessels. Isoform short cleaves fibronectin and also collagen type III, but at lower rate. It has no effect on type I, II, IV and V collagen. However, upon interaction with CSPG4, it may be involved in degradation and invasion of type I collagen by melanoma cells. |
| Cell Pathway/ Category | Primary Polyclonal Antibody |
| Protein MW | 69kDa |
| Usage | For Research Use Only! Not for diagnostic or therapeutic procedures. |